tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Lee, 64 are a BUY (86.49%), 10 are a HOLD (13.51%).
Analyst Sean Lee, carries an average stock price target met ratio of 31.45% that have a potential upside of 43.39% achieved within 85 days. Previously, Sean Lee worked at HCWAINWRIGHT.
Sean Lee’s has documented 137 price targets and ratings displayed on 13 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VSTM, Verastem at 08-May-2025.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 1/22/2025. The price target of $40 was fulfilled within 2 days with a profit of $6.33 (18.8%) receiving and performance score of 94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$4
$2.11 (111.64%)
$6
1 months 2 days ago
(08-Apr-2025)
1/5 (20%)
$1.89 (89.57%)
54
Buy
$4
2 years 5 months 25 days ago
(16-Nov-2022)
1/2 (50%)
$0.72 (21.95%)
73
Buy
$12
$10.11 (534.92%)
2 years 8 months 26 days ago
(14-Aug-2022)
1/2 (50%)
$7.98 (198.51%)
308
Buy
$50
2 years 11 months 15 days ago
(26-May-2022)
0/1 (0%)
$32.3 (182.49%)
Which stock is Sean Lee is most bullish on?
Which stock is Sean Lee is most reserved on?
What Year was the first public recommendation made by Sean Lee?
